You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 健友股份漲近6% 獲美國肝素鈉注射液USP藥品註冊批件
格隆匯 02-27 10:55
格隆匯2月27日丨健友股份(603707.SH)現報52.23元,漲5.94%,暫成交1.7億元,最新總市值375億元。健友股份昨晚發公告稱,公司近日收到美國食品藥品監督管理局簽發的肝素鈉注射液USP ANDA批准通知,肝素鈉注射液USP主要用於抗凝、抗血栓等症狀的治療。公司肝素鈉注射液USP(西林瓶)共9個規格已全部獲得美國FDA批准,前期獲批的8個規格已在美國上市形成銷售,新批准規格近期也將安排在美國上市銷售,有望對公司今年經營業績產生積極影響。據悉,截至目前,公司在肝素鈉注射液USP研發項目上已投入研發費用約人民幣2644.21萬元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account